Vico Therapeutics

Rewriting the Code of Neurological Disease

Leiden · Founded 2019 · $103.0M raised

Headquarters
Leiden
Founded
2019
Business Model
B2B
Website
vicotx.com
Total Funding
$103.0M
Last Round
$12.0M Extension RoundJun 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Vico Therapeutics is a neurology genetic medicine company headquartered in Leiden, the Netherlands, pioneering targeted treatments for devastating disorders. Founded in 2019, the company's lead program, VO659, is an antisense oligonucleotide (ASO) therapy designed to target the CAG repeat expansion mutation underlying Huntington's disease and multiple spinocerebellar ataxias, addressing nine distinct polyglutamine diseases through a single molecule while carefully preserving essential protein function.

Summary

Vico Therapeutics is a Biotech company based in Leiden, founded in 2019. It has raised $103.0M in total across 3 rounds, most recently a $12.0M Extension Round in Jun 2024. Investors include Kurma Partners, Seroba Life Sciences and LSP Life Sciences Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundJun 2024
$12.0M

Sign up to see all 3 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vico Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vico-therapeutics"><img src="https://indexed.vc/api/badge/company/vico-therapeutics" alt="Vico Therapeutics on Indexed.vc" width="260" height="76" /></a>